Research across Intracranial Hemorrhage
Related studies from across the Intracranial Hemorrhage family.
Part of Intracranial Hemorrhage
4 published articles · Updated continuously
6 trials tracked for intraventricular hemorrhage: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 61 citations.
Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Clinical evidence regarding the management of intraventricular hemorrhage includes evaluations of caffeine citrate and surgical drainage technologies. Caffeine citrate was associated with a Bayley Scales of Infant Development Cognitive Score of 85.6 to 88.0 at 2 years of age 1.
The use of Bactiseal TM EVD demonstrated specific metrics for catheter management, including an average of approximately 9.5 to 14 days to proven infection and a mean duration of roughly 8.7 to 10.4 days with the indwelling catheter 2.
In studies evaluating Alteplase, there was no statistically significant difference in functional outcomes. Results showed no significant difference in the proportion of participants achieving an mRS score of ↄ or less (p=0.554), ordinal mRS scores (p=0.484), or mRS scores of ↄ or less (p=0.552) 3.
AI synthesis of 5 cited trials, updated Jun 24, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
Related studies from across the Intracranial Hemorrhage family.